Clinical review report. Ozenoxacin 1% cream (Ozanex) (Ferrer internacional, S.A.) : indication : the topical treatment of impetigo in patients aged two months and older.

Clinical review report. indication : the topical treatment of impetigo in patients aged two months and older. Ozenoxacin 1% cream (Ozanex) (Ferrer internacional, S.A.) :

The objective of this report is to perform a systematic review of the beneficial and harmful effects of ozenoxacin 1% cream for the topical treatment of impetigo in patients aged two months and older.

Saved in:

Bibliographic Details
Online Access:	Full text
Format:	Electronic eBook
Language:	English
Published:	Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 2018
Series:	Common drug review clinical review report.
Subjects:	Impetigo > drug therapy. Infant. Child. Aminopyridines > therapeutic use. Quinolones > therapeutic use. Treatment Outcome. Children. Family members. Canada. Systematic Review. Tables.

CADTH Canadian Drug Expert Committee recommendation. Ozenoxacin 1% cream (Ozanex -- Ferrer Internacional, S.A.) : indication: the topical treatment of impetigo in patients aged two...

Version: Final.

Published 2018

Full text

Electronic eBook

Pharmacoeconomic review report. Ozenoxacin 1% cream (Ozanex), (Ferrer internacional, S.A.) : indication : the topical treatment of impetigo in patients aged two months and older.